Let’s be blunt: biotech funding in 2026 is not about great science anymore. It is about proven science.
Venture capitalists are actively seeking out biotechs with existing data sets and de-risked pipelines; the days of backing a tantalizing hypothesis and a great presentation have passed. They are looking for evidence of preliminary findings, assay validation, repeatability, and confirmation that the technology is functional in an actual laboratory setting.
The resulting dilemma for new founders is this: you need money to produce the data, but you can’t get the money unless you have the data.
BADASS Labs is designed to solve that problem.
2026 Funding Realities: A Bigger Pot, Higher Standards
In the first half of 2026, global biotech venture capital poured in around $65 billion, while initial public offerings brought in $4.5 billion. The average Series A biotech valuation hit $79.4 million; solid Series B biotechs are now worth $150 million or more.
That capital, however, is landing primarily with the de-risked. The industry is seeing more due diligence, more challenging inquiry, and a demand for better data from VCs than ever before. The distance between a “interesting idea” and a “fundable” one continues to grow.
Unless you are a founder with an intriguing concept who doesn’t have access to the lab space required to prove its proof-of-concept, then you are on the losing side of that increasing distance.
Why Data is King in 2026
Biotech is still a high-risk, high-reward game, and we have all heard the statistics:
- How many years does a drug take to develop?
- How difficult is cell therapy manufacturing?
- What kinds of regulatory hurdles does gene therapy face?
- Does your climate tech show scalability?
VCs want the following to help mitigate the risk before funding any projects:
- A hint of efficacy.
- A track record for replicating manufacturing processes.
- Clearly stated competitive advantages.
- Regulatory readiness.
- Your team’s capacity to deliver on their promises.
To be able to show this kind of evidence, you will need access to a working laboratory that provides equipment and resources that allows for experimentation at a reasonable pace — not a university research lab that is in high demand or one that is extremely expensive to build out to your specific specifications.
BADASS Labs: The Infrastructure to De-Risk Your Science
Dr. David Kiewlich spent 18 months looking for appropriate lab space after founding six biotech companies and having nearly twenty-five years of professional experience in oncology and cell-based therapies. That search formed the basis of BADASS Labs and its aim: clear the obstacles between our scientist clients and their research.
- Top-Tier Lab Equipment, 24/7 Our Alameda, CA locations provide 24/7 access to a wide range of research-grade technologies, from flow cytometers to real-time PCR to cell culture rooms to biosafety hoods to microscopy.
Good data depends on repeated cycles of experimentation and analysis. The goal is to be able to run tests, interpret the results, tweak your methods, and start again immediately if need be. Quickening the pace of the process allows data to be generated at a speed faster than ever before, which helps to get you closer to funding as soon as possible.
- No Equity, No IP The majority of biotech incubators claim a piece of your equity and a piece of your IP. In the current funding atmosphere, a clean cap table and a clean IP status are more important than ever.
BADASS Labs claims no equity or IP from our clients. We are a nonprofit 501(c)(3), and our purpose is to help innovators succeed — while allowing them to claim their own successes, too.
- Flat-Fee Pricing for Maximum Runway Every bit of funding counts. It is entirely typical for a startup to invest hundreds of thousands of dollars just in construction before it runs a single experiment.
Our flat-fee includes the lab space itself and its equipment, the maintenance for both, the cost of meeting all safety and regulatory requirements, and services and amenities that make up the lab. Predictable spending helps you to maximize your runway and spend the money that investors want to see spent on results.
- Terms That Work With Your R&D The R&D process rarely adheres to an arbitrary timeline.
BADASS Labs asks only that you sign up for a minimum of three months, without the need to have a graduation plan enforced. Spend as much time as you need in our labs to test out your technology, build a solid data package, and position yourself for successful fundraising.
- A Community That Moves You Faster De-risking isn’t just about hardware—it’s about know-how.
BADASS Labs connects a growing community of researchers and founders working in cell therapy, oncology, climate tech, and biomanufacturing. Whether it’s a casual chat with a peer, an exchange of critical feedback, or accessing the experience of someone who’s been there, it’s all part of how you de-risk your venture. You can avoid costly mistakes and find yourself a step ahead of those trying the same experiments in the dark.
From Data to Dollars
BADASS Labs member companies have collectively raised more than $900 million to date, with a success rate ranging from 89–95% (an average of roughly 10%).
Our members come into meetings with reproducible results, validated methodologies, and data-backed narratives. They’re not pitching ideas. They’re pitching data, and it’s data that gets you to the right people. And, as we’ll all acknowledge, that is what is happening in 2026.
Climate Tech: The Same De-Risking Playbook
Proof of concept doesn’t only apply to biotech companies.
The market for climate-related technologies globally is projected to increase from $31.68 billion in 2025 to $281.97 billion by 2035. However, climate tech companies still need to prove viability to their investors before receiving a check.
Battery materials require performance data. Biofuels require yield validation. Carbon capture technologies need efficiency validation. Sustainable biomanufacturing needs to demonstrate that its process is economically feasible.
BADASS Labs supports climate tech innovators by providing the same research infrastructure, no-equity business model, and collaborative community, just like we have provided for bio founders who have gone on to great success.
Your Next Move: Stop Pitching Ideas, Start Generating Data
If you’re trying to navigate the investment landscape as it exists in 2026, then the road ahead is straightforward. Get your data now.
For every day you don’t have access to a reliable, professional, and affordable laboratory space, a company that does have access will be able to make the same experiments with the proof-of-concept results that investors want to see.
The BADASS Labs model has world-class wet labs and offices in Alameda, CA. We offer 24/7 access to the tools you need, no equity stakes, no IP claims, flat-fee pricing, and access to an amazing community of scientists who’ve gone on to raise more than $900 million to date. In short, you either succeed or learn, you don’t fail.
BADASS Labs is the brainchild of Dr. Kiewlich who, as a researcher in academia, had a hard time finding the space he needed. It’s an organization created specifically for researchers who don’t want to have to waste their time finding the right place to work and instead want to focus on making discoveries.
You need data to raise your seed and series A funding, and to do that, you need the best environment to create that data in.
Ready to join BADASS Labs? Book a tour of our Alameda facilities, speak with our community, or apply for lab space here.
Frequently Asked Questions
How quickly can I start running experiments at BADASS Labs? Qualified startup companies can usually get into lab space within a few weeks from application. We provide safety training, compliance guidance, and onboarding to allow for a fast transition to the labs.
What types of companies are best suited for BADASS Labs? Our members are typically early-stage biotech companies ranging from pre-seed to Series B, as well as some biotechnology and climate technology startups working in cell therapy, gene therapy, oncology, AAV manufacturing, battery materials, biofuels, carbon capture, and sustainable biomanufacturing.
How does the zero-equity model work? BADASS Labs is a 501(c)(3) nonprofit which operates its labs and offices through a flat rental fee rather than taking an equity stake in your company. With this model, you are in full control of your own equity and intellectual property.
Can BADASS Labs help me prepare for investor meetings? While we are not a venture fund or typical accelerator, our community members offer peer-to-peer support. You gain access to an established network of successful founders who can share their fundraising stories and provide feedback on how to position your company before investors.
Do you have locations outside the Bay Area? Currently, BADASS Labs operates in Alameda, California. We are also expanding our presence with a location in Salt Lake City. Regardless of which BADASS Labs location you choose, the same BADASS Labs model applies. You retain full ownership of your equity and intellectual property, have unrestricted 24/7 access to our facilities, operate on a flat-fee payment model, and gain access to a collaborative, supportive research community.